JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

17β-HSD

17β-Hydroxysteroid dehydrogenase (17β-HSD) inhibitors in this category mostly target one aldo-keto reductase. Aldo-keto reductase family 1 member C3 (AKR1C3), also called type 5 17β-HSD, reduces androstenedione to testosterone in peripheral tissues. Its close relatives AKR1C1 and AKR1C2 act mainly on other steroids, inactivating progesterone and 5α-dihydrotestosterone. These isoforms share high sequence identity, so selectivity between them is a central question in inhibitor research. AKR1C3-IN-1 and AKR1C2/3-IN-1 address AKR1C3, while AKR1C1-IN-1 is directed at AKR1C1. Stylopine, a protoberberine alkaloid, is also listed as an AKR1C3 inhibitor. AKR1B10-IN-1 targets AKR1B10, a reductase of a neighboring subfamily that is studied in retinoid and lipid metabolism.

Cat. No.

A69034

CAS No.

2758802-33-2

HSD17B13-IN-31

HSD17B13-IN-31 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 of less than 0.1 μM for estradiol and less than 1 μM for leukotriene B3. This compound is crucial in researching nonalcoholic fatty liver diseases (NAFLDs), particularly nonalcoholic steatohepatitis (NASH), by modulating lipid metabolism and inflammation. HSD17B13-IN-31 serves as a valuable tool for studying the role of HSD17B13 in liver-related disorders and therapeutic interventions.

View Details

Out of stock
All 3 sizes
Cat. No.

A69035

CAS No.

932495-16-4

CRT0083914

CRT0083914 is a selective non-carboxylate inhibitor of the enzyme AKR1C3. This compound exhibits significant biological activity against AKR1C3, making it a valuable tool for studying its role in colon cancer. Researchers can utilize CRT0083914 to explore its potential therapeutic effects and mechanistic insights in the context of cancer research.

In stock View Details

25 mg

$1,275.00

50 mg

$1,625.00

All 3 sizes
Cat. No.

A69036

CAS No.

2770246-10-9

HSD17B13-IN-42

HSD17B13-IN-42 targets hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) as a potent inhibitor, exhibiting an IC50 of less than 0.1 μM with estradiol substrates. This compound is significant in the study of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH), making it a valuable tool for researchers investigating metabolic disorders and liver pathologies.

View Details

Out of stock
All 3 sizes
Cat. No.

A69037

CAS No.

2770246-71-2

HSD17B13-IN-37

HSD17B13-IN-37 is a selective inhibitor of 17β-Hydroxysteroid dehydrogenase type 13 (HSD17B13), demonstrating an IC50 of less than 0.1 μM for estradiol. This compound is utilized in research focused on nonalcoholic fatty liver disease (NAFLD), where it aids in elucidating the role of HSD17B13 in lipid metabolism and liver pathophysiology. Its potent inhibitory activity makes it a valuable tool for investigating therapeutic strategies targeting HSD17B13-related pathways.

View Details

Out of stock
All 3 sizes
Cat. No.

A69038

CAS No.

2770246-34-7

HSD17B13-IN-102

HSD17B13-IN-102 is a potent inhibitor of the enzyme hydroxysteroid dehydrogenase 17 beta 13 (HSD17B13), demonstrating an IC50 value of less than 0.1 μM with estradiol. This compound is instrumental in research focused on steroid metabolism and associated diseases, particularly in the context of liver function and metabolic disorders. Its selective inhibition provides a valuable tool for investigating the biological roles of HSD17B13 in various physiological and pathological conditions.

View Details

Out of stock
All 3 sizes
Cat. No.

A69039

CAS No.

2758802-09-2

HSD17B13-IN-16

HSD17B13-IN-16 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 of less than 0.1 μM for estradiol and less than 1 μM for leukotriene B3. This compound has significant relevance in the study of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH). HSD17B13-IN-16 serves as a valuable tool for researchers investigating metabolic disorders and potential therapeutic interventions in liver diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69040

CAS No.

2770246-69-8

HSD17B13-IN-35

HSD17B13-IN-35 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 of less than 0.1 μM when estradiol is used as a substrate. This compound is significant in the context of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH), by targeting metabolic pathways involved in lipid metabolism. Its effective inhibition of HSD17B13 makes it a valuable reagent for research into therapeutic strategies for liver-related disorders.

View Details

Out of stock
All 3 sizes
Cat. No.

A69041

CAS No.

2770247-51-1

HSD17B13-IN-63

HSD17B13-IN-63 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC50 value of ≤ 0.1 μM for estradiol. This compound is valuable for research applications related to liver diseases, metabolic disorders, and cardiovascular conditions, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). Its efficacy in modulating HSD17B13 activity provides insights into the underlying mechanisms of these diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69042

CAS No.

2770246-86-9

HSD17B13-IN-57

HSD17B13-IN-57 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 value of ≤ 0.1 μM for estradiol. This compound is relevant for investigations into liver diseases, metabolic disorders, and cardiovascular conditions, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). HSD17B13-IN-57 serves as a valuable tool for studying the biochemical pathways involved in these diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69043

CAS No.

2770246-42-7

HSD17B13-IN-28

HSD17B13-IN-28 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 of less than 0.1 μM for estradiol as substrate. This compound is significant in the study of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH). Its ability to modulate HSD17B13 activity makes it a valuable tool for exploring the metabolic mechanisms underpinning liver disorders and evaluating potential therapeutic strategies.

View Details

Out of stock
All 3 sizes
Cat. No.

A69044

CAS No.

2770246-33-6

HSD17B13-IN-100

HSD17B13-IN-100 is a potent inhibitor of HSD17B13, exhibiting an IC50 value of less than 0.1 μM in the presence of estradiol. This compound is essential for researchers investigating the role of HSD17B13 in steroid metabolism and related pathways. Its selective inhibition can facilitate studies on various conditions associated with altered steroidogenesis, including liver diseases and metabolic disorders.

View Details

Out of stock
All 3 sizes
Cat. No.

A69045

CAS No.

2770247-42-0

HSD17B13-IN-80

HSD17B13-IN-80 is a selective inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 value of ≤ 0.1 μM for estradiol. This compound plays a crucial role in research focusing on liver diseases, metabolic disorders, and cardiovascular conditions, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). Its potent inhibitory activity makes it a valuable tool for investigating the pathophysiological mechanisms underlying these diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69046

CAS No.

2912452-29-8

HSD17B13-IN-44

HSD17B13-IN-44 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of less than 0.1 μM for estradiol. This compound is valuable for investigating its role in liver diseases and metabolic disorders, providing insights into the biochemical pathways associated with these conditions. Researchers can utilize HSD17B13-IN-44 to explore therapeutic targets and validate the significance of HSD17B13 in various biological processes.

View Details

Out of stock
All 3 sizes
Cat. No.

A69047

CAS No.

2912452-50-5

HSD17B13-IN-45

HSD17B13-IN-45 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 value of less than 0.1 μM for estradiol. This compound is instrumental in exploring pathways associated with liver diseases and metabolic disorders. Researchers can utilize HSD17B13-IN-45 to investigate the role of HSD17B13 in various biological contexts and its potential as a therapeutic target.

View Details

Out of stock
All 3 sizes
Cat. No.

A69048

CAS No.

2770247-45-3

HSD17B13-IN-81

HSD17B13-IN-81 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 value of ≤ 0.1 μM for estradiol. This compound is utilized in research focused on liver diseases, metabolic disorders, and cardiovascular diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Additionally, it serves as a valuable tool in studies related to drug-induced liver injury (DILI).

View Details

Out of stock
All 3 sizes
Cat. No.

A69049

CAS No.

2770246-06-3

HSD17B13-IN-40

HSD17B13-IN-40 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 of less than 0.1 μM against estradiol substrates. This compound is significant for research related to nonalcoholic fatty liver diseases (NAFLD), particularly nonalcoholic steatohepatitis (NASH), as it may provide insights into the modulation of lipid metabolism and inflammatory pathways. The compound's inhibitory action on HSD17B13 highlights its potential utility in exploring therapeutic strategies for metabolic disorders.

View Details

Out of stock
All 3 sizes
Cat. No.

A69050

CAS No.

2770246-89-2

HSD17B13-IN-58

HSD17B13-IN-58 is a potent inhibitor of 17β-Hydroxysteroid dehydrogenase type 13 (HSD17B13), demonstrating an IC50 of less than 0.1 μM for estradiol. This compound is primarily utilized in the research of nonalcoholic fatty liver diseases (NAFLD), contributing to the understanding of lipid metabolism and hormonal regulation in hepatic disorders. Its selective inhibition offers valuable insights into therapeutic strategies targeting HSD17B13 in liver-related diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69051

CAS No.

2730027-85-5

HSD17B13-IN-33

HSD17B13-IN-33 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of less than 0.1 μM for estradiol. This compound plays a crucial role in research focused on liver diseases, metabolic disorders, and cardiovascular conditions, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). Its selective activity makes it a valuable tool for investigating the therapeutic potential in these diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69052

CAS No.

2770246-58-5

HSD17B13-IN-30

HSD17B13-IN-30 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC50 of less than 0.1 μM for estradiol substrates. This compound is significant in the study of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH), due to its role in modulating steroid metabolism and fatty liver progression. HSD17B13-IN-30 facilitates research into therapeutic approaches for liver-related metabolic disorders.

View Details

Out of stock
All 3 sizes
Cat. No.

A69053

CAS No.

1318265-18-7

17β-HSD1-IN-2

17β-HSD1-IN-2 is a non-estrogenic, steroidal covalent irreversible inhibitor of 17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1), exhibiting a Ki of 368 nM. This compound demonstrates potential for studying estrogen-dependent disorders, facilitating research into therapeutic strategies for conditions influenced by estrogen metabolism. Its selective inhibition of 17β-HSD1 offers valuable insights into the enzyme's role in various biological processes and disease states.

In stock View Details

1 mg

$620.00

5 mg

$1,305.00

All 5 sizes
Cat. No.

A69054

CAS No.

2758802-05-8

HSD17B13-IN-14

HSD17B13-IN-14 is a selective inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 of ≤ 1 μM for leukotriene B3 and ≤ 0.1 μM for estradiol. This compound is valuable for research into hepatic conditions, metabolic diseases, and cardiovascular disorders, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). Its potent inhibition of HSD17B13 makes it an important tool for studying the underlying mechanisms of these diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69055

CAS No.

2409783-34-0

Gatuzosiran

Gatuzosiran is a small interfering RNA (siRNA) that targets and reduces the synthesis of 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13). This compound plays a crucial role in research focused on fatty liver disease, providing insights into the molecular mechanisms underlying lipid metabolism and liver function. Its ability to modulate HSD17B13 expression makes it a valuable tool for studying the pathophysiology of liver diseases.

View Details

Out of stock
All 3 sizes
Cat. No.

A69056

CAS No.

2770246-81-4

HSD17B13-IN-53

HSD17B13-IN-53 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC50 value of ≤ 0.1 μM for estradiol. This compound is valuable for research into liver-related pathologies, metabolic disorders, and cardiovascular diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), as well as studies on drug-induced liver injury (DILI).

View Details

Out of stock
All 3 sizes
Cat. No.

A69057

CAS No.

2912455-14-0

HSD17B13-IN-47

HSD17B13-IN-47 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 value of less than 0.1 μM for estradiol. This compound is valuable for studying the role of HSD17B13 in liver diseases and metabolic disorders, facilitating research into therapeutic interventions targeting these conditions.

View Details

Out of stock
All 3 sizes
Cat. No.

A69058

CAS No.

2770247-41-9

HSD17B13-IN-83

HSD17B13-IN-83 is a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 value of ≤ 0.1 μM for estradiol. This compound is relevant for investigations into liver and metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). Its specificity and efficacy make it a valuable tool for advancing research in the fields of hepatology and cardiovascular health.

View Details

Out of stock
All 3 sizes

Loading...